CervoMed Inc.(CRVO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,956 of 2,960 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
CRVO Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for CervoMed Inc. (CRVO), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CRVO at 3.9/100 on a 32-signal composite quality model, placing it at rank #2,956 of 2,960 stocks — the bottom half of the AI-ranked universe. Top institutional holders of CRVO by reported 13-F value include Woodline Partners, VANGUARD CAPITAL MANAGEMENT, SABBY MANAGEMENT, based on the most recent SEC filings. CRVO trades on the Nasdaq exchange and files with the SEC under CIK 1053691. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRVO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CervoMed Inc. directly from SEC EDGAR. CervoMed Inc.'s 13F Pro composite quality score has ranged between 3 and 5 since 2026, currently 3.9 — a stable long-term trajectory across 9 quarterly and live scoring snapshots.
Revenue
Q2 2026
$0.00
Net Income
Q2 2026
$-6.6M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-58.9% YoYNet Income
-65.5% YoYOperating Income
-55.2% YoYEPS (Diluted)
Total Assets
-46.9% YoYOp. Cash Flow
-41.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.0M -58.9% | $9.7M +36.3% | $7.1M | $0.00 | — | — |
| Net Income | $-27.0M -65.5% | $-16.3M -650.1% | $-2.2M +62.6% | $-5.8M +75.9% | $-24.1M -69.9% | $-14.2M |
| Operating Income | $-28.3M -55.2% | $-18.2M -133.3% | $-7.8M -124.8% | $-3.5M +85.9% | $-24.7M -54.5% | $-16.0M |
| EPS (Diluted) | — | — | — | $509722.75 +4.7% | $486714.75 -99.1% | $53831973.00 |
| Total Assets | $22.9M -46.9% | $43.1M +332.0% | $10.0M +139.9% | $4.2M -89.0% | $37.8M +36.5% | $27.7M |
| Operating Cash Flow | $-23.4M -41.9% | $-16.5M -121.9% | $-7.4M -189.6% | $-2.6M +82.3% | $-14.5M -7.0% | $-13.6M |
Get alerted when CRVO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CervoMed Inc. including:
Top Institutional Holders of CRVO
Woodline Partners LP
$2.1M688,987 shVANGUARD CAPITAL MANAGEMENT LLC
$980.2K316,202 shSABBY MANAGEMENT, LLC
$771.5K248,880 shGEODE CAPITAL MANAGEMENT, LLC
$207.5K66,923 shBlackRock, Inc.
$166.9K53,845 shByrne Asset Management LLC
$158.9K51,250 shCITIZENS FINANCIAL GROUP INC/RI
$116.2K37,477 shVANGUARD FIDUCIARY TRUST CO
$112.1K36,151 shJANE STREET GROUP, LLC
$99.9K32,231 shTHOMPSON DAVIS & CO., INC.
$92.2K29,750 sh
| Fund | Value | Shares |
|---|---|---|
| Woodline Partners LP | $2.1M | 688,987 |
| VANGUARD CAPITAL MANAGEMENT LLC | $980.2K | 316,202 |
| SABBY MANAGEMENT, LLC | $771.5K | 248,880 |
| GEODE CAPITAL MANAGEMENT, LLC | $207.5K | 66,923 |
| BlackRock, Inc. | $166.9K | 53,845 |
| Byrne Asset Management LLC | $158.9K | 51,250 |
| CITIZENS FINANCIAL GROUP INC/RI | $116.2K | 37,477 |
| VANGUARD FIDUCIARY TRUST CO | $112.1K | 36,151 |
| JANE STREET GROUP, LLC | $99.9K | 32,231 |
| THOMPSON DAVIS & CO., INC. | $92.2K | 29,750 |
More Healthcare Companies
View all Healthcare →Put CRVO on your watchlist
Track score changes the day CervoMed Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CRVO a good stock to buy?
13F Pro's AI-powered analysis of CervoMed Inc. (CRVO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CRVO are available on the CRVO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CRVO is classified as a small company.
Which hedge funds own CRVO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CRVO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CervoMed Inc.'s investment landscape.